| Patient | Phillis Wheatley |
|---|---|
| Date of birth | 1753-07-01 |
| Identifiers | MRN HR-EN015-SYN-TD; SSN (made up) 000-15-3360 |
| Document date | 1773-09-21 |
| Author | Abena Hartley-Okonkwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Wheeze and tight chest for three days with a cold, a week after returning from abroad. [S]
Miss Wheatley returned from abroad eight days ago. She was well all summer: she used her reliever only two or three times a month, never needed the standby prednisone, and feels the time away did her good. Five days ago, in the first cold, damp days after her return, she caught a cold with a sore throat and runny nose. For three days her chest has been tight and wheezy; she woke twice last night and has used six to eight extra inhalations of budesonide-formoterol on each of the last two days, as her action plan allows. This morning her peak flow was 280 L/min, in the yellow zone, and she called the clinic. She can speak in full sentences and has no chest pain or green sputum. She has been very busy since her return and is anxious not to lose time. [S]
| Element | Detail |
|---|---|
| Onset | Cold five days ago; asthma worse for three days |
| Severity | Woke twice last night; six to eight reliever inhalations a day; peak flow 280 L/min this morning |
| Context | As-needed budesonide-formoterol (GINA track 1, step 2); yellow zone of her action plan |
| Associated signs and symptoms | Sore throat and runny nose; temperature 37.6 °C; no chest pain or purulent sputum |
| Risk history | No previous exacerbation needing oral corticosteroids, emergency care or admission |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; low-grade temperature; no rigors |
| Respiratory | Positive | Wheeze, chest tightness, dry cough and night waking; no hemoptysis |
| Ears, nose, mouth, and throat | Positive | Sore throat and clear nasal discharge |
| Cardiovascular | Negative | No chest pain or palpitations |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day | One inhalation as needed | Respiratory tract route | 1773-02-23 to 1773-09-21 | completed | S |
| Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs | 40 mg each morning for five days if the action plan directs | Oral route | 1773-04-06 to 1773-10-26 | stopped | S |
| Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness | One tablet daily as needed at sea | Oral route | 1773-04-06 to 1773-09-21 | completed | S |
| Folic acid 0.4 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1773-04-27 | active | S |
| Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed, no more than 12 inhalations a day | One inhalation twice daily plus one as needed | Respiratory tract route | 1773-09-21 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1773-09-21 | Body height | 152 | cm | S |
| 1773-09-21 | Body weight | 47.2 | kg | S |
| 1773-09-21 | Body mass index (BMI) [Ratio] | 20.4 | kg/m2 | S |
| 1773-09-21 | Systolic blood pressure | 108 | mm[Hg] | S |
| 1773-09-21 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 1773-09-21 | Heart rate | 98 | /min | S |
| 1773-09-21 | Respiratory rate | 20 | /min | S |
| 1773-09-21 | Body temperature | 37.6 | Cel | S |
| 1773-09-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1773-09-21 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 270 | L/min | 80 percent of her personal best of 400 L/min | Low | S |
Vital signs recorded on 1773-09-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert, sitting upright, speaking in full sentences; no accessory muscle use |
| Vital signs | Pulse 98, respiratory rate 20, oxygen saturation 96 percent on room air, temperature 37.6 °C; peak flow 270 L/min (68 percent of her best) |
| Head, eyes, ears, nose, and throat | Red throat without exudate; clear nasal discharge; no sinus tenderness |
| Respiratory | Scattered expiratory wheeze with good air entry; no crackles |
| Reassessment after 30 minutes | After two inhalations of budesonide-formoterol with a spacer: peak flow 330 L/min (82 percent), wheeze much reduced, pulse 90, respiratory rate 16 |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNO | resolved | confirmed | R06.2 | S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit. |
| Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, colds | active | confirmed | J45.30 | S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma. |
| Asthma exacerbation with a cold a week after returning from abroad: three days of wheeze, chest tightness and waking at night despite six to eight reliever inhalations a day; peak flow 270 L/min (68 percent of her best of 400), oxygen saturation 96 percent; 330 L/min after treatment in clinic; treated without oral corticosteroids; resolved | active | confirmed | J45.31 | S — Synthetic exacerbation anchored to her own letter describing a cold and asthma after her return; the clinical details are synthetic. |
| Prone to seasickness on boat trips; meclizine for the sea crossing; resolved on her return | active | confirmed | T75.3XXA | S — Synthetic travel-related problem. |
| Pregnancy planning: not sexually active and no contraception wanted now; she may wish to have children one day; folic acid by her choice, and asthma care planned before and during any pregnancy | active | confirmed | Z31.69 | S — Synthetic reproductive health counselling; not a claim about her real life. |
Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020)
Follow-up: Nurse telephone call in two days. Clinic review within a week. Emergency care for any red-zone sign. Next scheduled visit 1773-10-26: asthma review after an exacerbation with a cold on her return from abroad: control, repeat spirometry and FeNO, the winter plan, completion of vaccines, and her changed circumstances. [S]